Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2007-07-17
2007-07-17
Ewoldt, G. R. (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C514S002600, C514S008100, C530S324000, C530S868000, C424S810000
Reexamination Certificate
active
10026911
ABSTRACT:
The present invention relates to a pharmaceutical composition containing a peptide and a pharmaceutically acceptable carrier or diluent wherein the peptide has a length of 8 to 50 amino acids, at least three preferably consecutive amino acids of the peptide are identical to at least three amino acids which appear in close vicinity on the molecular surface of an allergenic protein, and said at least three amino acids are solvent-exposed amino acids in the allergenic protein. The invention also concerns a method for the preparation of the pharmaceutical composition.
REFERENCES:
patent: 6878376 (2005-04-01), Spertini
patent: 0 714 662 (1994-07-01), None
patent: WO 96/27005 (1996-03-01), None
patent: WO 97/05258 (1996-08-01), None
patent: WO 97/24139 (1996-09-01), None
Friedl-Hajek et al., Clinical and experimental Allergy, 1999, vol. 29, pp. 478-487.
Ferreira et a., FASEB Journal, vol. 12, pp. 231-242, 1998.
Friedl-Hajek et al., Molecular Immunology, 1999, 36:639-645.
Swoboda et al. J. Biol. Chem. 1995, 270:2607-2613.
Colman, P.M., Research in Immunology, 1994, 145:33-36.
Vik et al., Int Arch Allergy Immunol, 1993, 101:89-94.
Mandler et al., J. Immunol. 1993, 150:407-418.
Harlow et al. , Antibodies, A Laboratory Manual, 1988, Cold Spring Harbor Laboratory, pp. 72-87.
Blumenthal et al. in Allergens and Allergen Immunotherapy, 3rd edition, 2004, pp. 37-50.
Denépoux, S. et al., “Molecular characterization of human IgG monoclonal antibodies specific for the major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance the anaphylactic reaction,”FEBS Letters,465: 39-46 (2000).
Gajhede, M. et al., “X-ray and NMR structure of Betv1, the origin of birch pollen allergy,”Nature Structural Biology,3(12): 1040-45 (Dec. 1996).
Niederberger, V. et al., “IgE antibodies to recombinant pollen allerens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE,”J. Allergy Clin. Immunol.,101: 258-264 (Feb. 1998).
Valent, P. et al., “Interleukin 3 activates human blood basophils via high-affinity binding sites,”Proc. Natl. Acad. Sci. USA, 86: 5542-46 (Jul. 1989).
Vrtala, S. et al., “Conversion of the Major Birch Pollen Allergen, Bet v 1, into Two Nonanaphylactic T Cell Epitope-containing Fragments,” J. Clin, Invest., 99(7): 1673-81 (Apr. 1997).
Vrtala, S. et al., “Properties of Tree and Grass Pollen Allergens: Reinvestigation of the Linkage between Solubility and Allergenicity,”Int. Arch. Allergy Immunol.102; 160-69 (1993).
European Search Report, EP 00 12 8659.
M. Focke et al.; “Nonallergenic Peptides from Surface-Exposed Areas or B-Cell Epitopes of Allergens for Specific Immunotherapy”,Int. Arch Allergy Immunol,124: 398-399 (2001).
E. Ganglberger et al.; “IgE Mimotopes of Birch Pollen Allergen Bet v. 1 Induce Blocking IgG in Mice”,Int. Arch Allergy Immunol,124: 395-397 (2001).
R. Furmonaviciene et al.; “The Use of Phage-Peptide Libraries to Define the Epitope Specificity of a Mouse Monoclonal Anti-Der p 1 Antibody Representative of a Major Component of the Human Immunoglobulin E Anti-Der p 1 Response”,Clinical and Experimental Allergy,29: 1563-1571 (1991).
E. Ganglberger et al.; “Allergen Mimotopes for 3-Dimensional Epitope Search and Induction of Antibodies Inhibiting Human IgE”,FASEB Journal,14: 2177-2184 (2000).
Focke Margarete
Kraft Dietrich
Mahler Vera
Sperr Wolfgang R.
Valent Peter
Ewoldt G. R.
Reed Smith LLP
Szperka Michael
LandOfFree
Allergy vaccines and their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allergy vaccines and their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allergy vaccines and their preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3746565